EXTH-26. PRMT5 AS A DRUGGABLE TARGET FOR GLIOBLASTOMA THERAPY

BACKGROUND: Glioblastoma (GBM) is the most common adult malignant brain tumor. In spite of standard multi modal therapy consisting of surgical resection followed by radiation and concurrent chemotherapy prognosis remains poor. As complexity of tumor heterogeneity is being increasingly recognized as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Banasavadi-Siddegowda, Yeshavanth Kumar, Welker, Alessandra M, Imitola, Jaime, Li, Chenglong, Zhang, Jianying, Beattie, Christine E, Baiocchi, Robert, Kaur, Balveen
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692644/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.320
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars